| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 07/14/2005 | WO2005023200A3 System and method for cooling internal tissue |
| 07/14/2005 | WO2005023198A3 Modafinil compositions |
| 07/14/2005 | WO2005016274A3 Rnai treatment of eye disease |
| 07/14/2005 | WO2005013888A3 Compounds, compositions and methods |
| 07/14/2005 | WO2005007118A3 Treatment or prevention of damage due to radiation exposure |
| 07/14/2005 | WO2005002515A3 Delivery of therapeutic compounds to the brain and other tissues |
| 07/14/2005 | WO2005002508A3 Macromolecular platinum chelates |
| 07/14/2005 | WO2005000212A8 Method for treating diseases using hsp90-inhibiting agents in combination with nuclear export inhibitors |
| 07/14/2005 | WO2004108085A3 Methods for the protection of memory and cognition |
| 07/14/2005 | WO2004098535A3 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 07/14/2005 | WO2004098528A3 Pyrazole-amine compounds useful as kinase inhibitors |
| 07/14/2005 | WO2004098514A3 Morinda citrifolia-based formulation for inhibiting metastasis of carcinogenic cells |
| 07/14/2005 | WO2004091537B1 Process for making gel films |
| 07/14/2005 | WO2004069179A3 Improved thickened beverages for dysphagia |
| 07/14/2005 | WO2004064769A3 Methods for making and using topical delivery agents |
| 07/14/2005 | WO2004017923A3 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 07/14/2005 | US20050155113 Expression vector comprising nucleotide sequences coding norwalk virus capsid protein for use in generating vaccine for prevention and treatment of gastrointestinal disorders |
| 07/14/2005 | US20050154204 Thioether-substituted benzamides as inhibitors of factor Xa |
| 07/14/2005 | US20050154180 Water-soluble polyaminoamides as sunscreen agents |
| 07/14/2005 | US20050154064 Dietetics; use in treatment of obesity, hepatic steatosis, or fatty liver, for reducing body weight, modulating body lipid metabolism, and reducing food intake |
| 07/14/2005 | US20050154053 Methods and compositions for immunomodulation |
| 07/14/2005 | US20050154030 Antimicrobial composition |
| 07/14/2005 | US20050154002 Novel oral bioavailable prodrugs |
| 07/14/2005 | US20050153970 N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity |
| 07/14/2005 | US20050153955 Compounds and compositions as protein kinase inhibitors |
| 07/14/2005 | US20050153948 Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone |
| 07/14/2005 | US20050153942 Heterocyclic inhibitors of MEK and methods of use thereof |
| 07/14/2005 | US20050153937 Administering encapsulated liposome nanoparticles of alendronate, pamidronate, clondronate, etidronate, tiludronate, gold, gallium, gadolinium, and/or selenium; treating hypersensitivity and/or complement activation-related pseudoallergy (CARPA) |
| 07/14/2005 | US20050153935 Compound and method for treating androgen-independent prostate cancer |
| 07/14/2005 | US20050153934 Chaperone-based therapy for Niemann-Pick disease |
| 07/14/2005 | US20050153928 Conjugates comprising a central nervous system-active drug linked to glucuronic acid or glucosamine through an amide bond and uses thereof |
| 07/14/2005 | US20050153384 Identifying inhibitors of intracellular protein fibrillization |
| 07/14/2005 | US20050153280 Viral propagation system and uses thereof |
| 07/14/2005 | US20050152979 comprising: a hydrophobic biologically active molecule or active agent; a polymeric carrier that renders the active agent soluble in water, and a reconstitution enhancer or enhancing agent; lyophilized |
| 07/14/2005 | US20050152931 Flexible and stable emulsion base for formulating stable compositions including suncare, cosmetic, and dermatological compositions |
| 07/14/2005 | US20050152860 bone morphogenetic protein 4 (BMP-4) decreases melanin synthesis in melanocytes by decreasing the activity of tyrosinase |
| 07/14/2005 | US20050152847 Novel formulation |
| 07/14/2005 | US20050152838 administering to mammals a Sindbis virus comprising gene that code detectable labels, concurrently with anticarcinogenic agents, and analyzing the amount of cancer cells in the body of the mammal |
| 07/14/2005 | US20050152739 Method and apparatus for improved stiffness in the linkage assembly of a flexible arm |
| 07/14/2005 | DE10361067A1 Medikamentöse Lipolyse von Fettansammlungen Drug lipolysis of fat accumulation |
| 07/14/2005 | CA2551474A1 Medical lipolysis of fat accumulations |
| 07/14/2005 | CA2550872A1 Surface protection of exposed biological tissues |
| 07/13/2005 | EP1551960A2 Hepatitis c viral-like particle purification |
| 07/13/2005 | EP1551813A2 Chemical compounds |
| 07/13/2005 | EP1551803A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 07/13/2005 | EP1551802A1 Indole-3-sulphur derivatives |
| 07/13/2005 | EP1551432A1 Argyrolobium roseum plant extracts for treating diabetes |
| 07/13/2005 | EP1551417A2 Three layer tear formulation |
| 07/13/2005 | EP1551416A2 Method for treating erectile dysfunction and increasing libido in men |
| 07/13/2005 | EP1551402A2 Abuse-resistant pharmaceutical compositions |
| 07/13/2005 | EP1551392A2 Novel lapacho compounds and methods of use thereof |
| 07/13/2005 | EP1551386A2 Methods and compositions for the treatment of lupus using clofarabine |
| 07/13/2005 | EP1551385A2 Selective cytokine inhibitory drugs for treating myelodysplastic syndrome |
| 07/13/2005 | EP1427711B1 Oxazolidinone and/or isoxazoline derivatives as antibacterial agents |
| 07/13/2005 | CN1639358A Multiple virus replicon culture systems |
| 07/13/2005 | CN1639136A Oxazolidinone and/or isoxazoline as antibacterial agents |
| 07/13/2005 | CN1639115A Semicarbazide derivatives and their use as antithrombotics |
| 07/13/2005 | CN1638805A Pharmaceutical formulation of IRESSA comprising a water-soluble cellulose derivative |
| 07/13/2005 | CN1638650A Composition improving age-related physiological deficits and increasing longevity |
| 07/13/2005 | CN1637208A Texturized cellulosic and lignocellulosic materials and compositions and composites made therefrom |
| 07/13/2005 | CN1636991A Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/13/2005 | CN1636597A Compounds for the treatment of female sexual dysfunction |
| 07/13/2005 | CN1210279C Thiazolo (4,5-D) pyrimidine compounds |
| 07/12/2005 | US6916961 Compound for use in the prevention and treatment of respiratory and nervous system disorders |
| 07/12/2005 | US6916927 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction |
| 07/12/2005 | US6916815 C-6 modified indazolylpyrrolotriazines |
| 07/12/2005 | CA2298142C Soya extract, process for its preparation and pharmaceutical composition |
| 07/12/2005 | CA2277168C Personal cleansing compositions |
| 07/07/2005 | WO2005060973A1 Reduction of toxicity of multi-targeting antifolates |
| 07/07/2005 | WO2005060954A1 Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof |
| 07/07/2005 | WO2005039495A3 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies |
| 07/07/2005 | WO2005034869A3 Compounds and compositions as protein kinase inhibitors |
| 07/07/2005 | WO2005032471A3 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/07/2005 | WO2005032461A3 Novel peptide with osteogenic activity |
| 07/07/2005 | WO2005020925A3 Method and apparatus for dosing solids |
| 07/07/2005 | WO2005016288A3 Methods and compositions for treatment of viral diseases |
| 07/07/2005 | WO2005016276A3 Sigma-1 receptor ligand with acetylcholinesterase inhibition properties |
| 07/07/2005 | WO2005016266A3 Methods for treating cardiovascular disease using a soluble ctla4 molecule |
| 07/07/2005 | WO2005007109A3 Methods and compositions for cancer therapy using a novel adenovirus |
| 07/07/2005 | WO2005007086A3 A method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture |
| 07/07/2005 | WO2005007082A8 Treatment of chronic bacterial infection |
| 07/07/2005 | WO2005007080A3 Methods and compositions for delivery of catecholic butanes for treatment of tumors |
| 07/07/2005 | WO2005007074A3 Gellan gum based oral controlled release dosage forms- a novel platform technology for gastric retention |
| 07/07/2005 | WO2004110356A3 Methods for modulating cell-to-cell adhesion using an agonist of c1inh-type protein activity |
| 07/07/2005 | WO2004105680A3 Oral care products comprising calcium metasilicates |
| 07/07/2005 | WO2004103304A3 Treatment of t-cell mediated diseases |
| 07/07/2005 | WO2004100868A3 Method of treating transplant rejection |
| 07/07/2005 | WO2004098516A3 Cyclic derivatives as modulators of chemokine receptor activity |
| 07/07/2005 | WO2004091500A3 Delivery of immune response modifier compounds |
| 07/07/2005 | WO2004084830A3 Method for treating alzheimer’s dementia |
| 07/07/2005 | WO2004080425A3 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 07/07/2005 | WO2004073655A3 Radiation phantom |
| 07/07/2005 | WO2004073605A3 Skin peeling composition and method |
| 07/07/2005 | WO2004071439A3 Immunoglobulin formulation and method of preparation thereof |
| 07/07/2005 | WO2004062570A3 Apparatus and method to measure platelet contractility |
| 07/07/2005 | WO2004045554A3 Cytomodulating peptides for treating interstitial cystitis |
| 07/07/2005 | WO2004034957A3 Methods for treatment of helicobacter pylori-associated disorders |
| 07/07/2005 | WO2004017914A8 Inhalation composition |
| 07/07/2005 | US20050149150 System and method for the photodynamic treatment of burns, wounds, and related skin disorders |
| 07/07/2005 | US20050148657 9, 10-Alpha, alpha-OH-taxane analogs and methods for production thereof |